Skip to content

Impact of Immediate SteNt ImplaNtatiOn Versus Deferred Stent ImplAntaTION on Clinical Outcomes in Patients with AnteRior Wall ST-segment Elevation Myocardial Infarction (INNOVATION-CORE)

Impact of Immediate SteNt ImplaNtatiOn Versus Deferred Stent ImplAntaTION on Clinical Outcomes in Patients with AnteRior Wall ST-segment Elevation Myocardial Infarction (INNOVATION-CORE)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0003309
Enrollment
460
Registered
2018-10-31
Start date
2018-04-03
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : The primary stent insertion group is the simultaneous use of balloon insertion and insertion of a stent on the day of an acute myocardial infarction. Stepwise stent insertion group is

Sponsors

Korea University Anam Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: • 19 years old or older • Typical ischemia chest pain of more than 30 minutes is persistent. • Two or more continuous pre-score induction phases show a rise of more than 0.1mV in new ST Segment. Or a new pedestal is observed. • In case of chest pain within 6 hours of symptom development • thrombolysis in myocardial infarction(TIMI) blood flow before medium technology is 0 or 1 or 2 • If the main vessels contributing to the infarction are the left anterior descending artery and the lesion is located between the median section of the guard opening (Os) • thrombolysis in myocardial infarction(TIMI) 3 blood flow is achieved by the administration of Abciximab in the coronary artery, frequency thrombosis and balloon expansion prior to stent surgery. • Subject to informed consent ; the subject shall receive oral confirmation of understanding of the treatment, risk, effectiveness and other therapeutic methods associated with the Staged.The patient is informed of the research

Exclusion criteria

Exclusion criteria: • In case of cardiac infarction or coronary bypass • Psychoactive shock • Rescue percutaneous coronary intervention(PCI) after thrombosis treatment • Life remaining due to accompanying diseases is expected to be within a year or not co-operative with the protocol. • If the Buckling Interposition is a strain-related vessel (the study includes the case where the Buckling Interprent lesion contains simply the Buckling Interstant lesions rather than the Antive related vessels) • Major dissection (Type C to F) occurs during treatment to secure TIMI blood flow including balloon expansion and is expected to be a risk of Acute closure when assigned as a step-by-step stent treatment. • A childbearing woman who is likely to be pregnant and has not been identified with appropriate methods of contraception.

Design outcomes

Primary

MeasureTime frame
The first result variable is a combination of death in 24 months after coronary surgery, hospitalization due to heart failure, recurrence of myocardial infarction, and the occurrence of a target vessel rehabilitation (TVR). If one of the cases occurs due to death, heart failure, recurrence of cardiac infarction, or TVR, it is defined as the occurrence of a combined clinical event.

Secondary

MeasureTime frame
Hospitalization due to death;heart death;Hospitalization due heart failure;recurrence of cardiac infarction;resuscitation of the target vessel;target lesion angioplasty;stent thrombosis;major bleeding reactions for stroke;abnormal response

Countries

Korea, Republic of

Contacts

Public ContactSu Oh

Korea University Anam Hospital

champagne05@naver.com+82-2-920-6731

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026